SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Klein Markus) "

Sökning: WFRF:(Klein Markus)

  • Resultat 51-53 av 53
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
51.
  • Wache, Christina, et al. (författare)
  • Myeloid-related protein 14 promote inflammation and injury in meningitis.
  • 2015
  • Ingår i: Journal of Infectious Diseases. - : Oxford University Press (OUP). - 1537-6613 .- 0022-1899. ; 212:2, s. 247-257
  • Tidskriftsartikel (refereegranskat)abstract
    • Neutrophilic inflammation often persists over days despite efficient antibiotic treatment and contributes to brain damage in bacterial meningitis. We proposed here that MRP14, an abundant cytosolic protein in myeloid cells, acts as an endogenous danger signal, driving inflammation and aggravating tissue injury.
  •  
52.
  • Wang, Anqi, et al. (författare)
  • Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants
  • 2023
  • Ingår i: Nature Genetics. - : Springer Nature. - 1061-4036 .- 1546-1718. ; 55:12, s. 2065-2074
  • Tidskriftsartikel (refereegranskat)abstract
    • The transferability and clinical value of genetic risk scores (GRSs) across populations remain limited due to an imbalance in genetic studies across ancestrally diverse populations. Here we conducted a multi-ancestry genome-wide association study of 156,319 prostate cancer cases and 788,443 controls of European, African, Asian and Hispanic men, reflecting a 57% increase in the number of non-European cases over previous prostate cancer genome-wide association studies. We identified 187 novel risk variants for prostate cancer, increasing the total number of risk variants to 451. An externally replicated multi-ancestry GRS was associated with risk that ranged from 1.8 (per standard deviation) in African ancestry men to 2.2 in European ancestry men. The GRS was associated with a greater risk of aggressive versus non-aggressive disease in men of African ancestry (P = 0.03). Our study presents novel prostate cancer susceptibility loci and a GRS with effective risk stratification across ancestry groups.
  •  
53.
  • Zweegman, Sonja, et al. (författare)
  • Melphalan, prednisone, and lenalidomide versus melphalan, prednisone, and thalidomide in untreated multiple myeloma.
  • 2016
  • Ingår i: Blood. - : American Society of Hematology. - 1528-0020 .- 0006-4971. ; 127:9, s. 1109-1116
  • Tidskriftsartikel (refereegranskat)abstract
    • The combination of melphalan, prednisone and thalidomide (MPT) is considered standard therapy for newly diagnosed patients with multiple myeloma (NDMM) who are ineligible for stem-cell transplantation. Long term treatment with thalidomide is hampered by neurotoxicity. Melphalan, prednisone and lenalidomide, followed by lenalidomide maintenance therapy showed promising results, without severe neuropathy emerging. We randomly assigned 668 NDMM patients, ineligible for stem-cell transplantation, between nine 4-weekly cycles of MPT followed by thalidomide maintenance until disease progression or unacceptable toxicity (MPT-T) and the same MP regimen with thalidomide being replaced by lenalidomide (MPR-R). This multicenter, open-label, randomised phase 3 trial was undertaken by HOVON and the NMSG. The primary endpoint was progression-free survival (PFS). The accrual for the study was completed in October 19, 2012. 318 patients were randomly assigned to receive MPT-T and 319 MPR-R. After a median follow up of 36 months PFS with MPT-T was 20 months (95% CI 18-23 months) versus 23 months (95% CI 19-27 months) with MPR-R (HR 0.87 [0.72-1.04], p=0.12). Response rates were similar, with ≥VGPR 47% and 45% respectively. Hematological toxicity was more pronounced with MPR-R, especially grade 3 and 4 neutropenia: 64 versus 27%. Neuropathy ≥ grade 3 was significantly higher in the MPT-T arm; 16% versus 2% in MPR-R, resulting in a significant shorter duration of maintenance therapy (5 versus 17 months in MPR-R), irrespective of age. MPR-R has no advantage over MPT-T concerning efficacy. The toxicity profile differed with clinically significant neuropathy during thalidomide maintenance versus myelosuppression with MPR.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 51-53 av 53
Typ av publikation
tidskriftsartikel (34)
konferensbidrag (11)
forskningsöversikt (4)
rapport (1)
annan publikation (1)
doktorsavhandling (1)
visa fler...
bokkapitel (1)
visa färre...
Typ av innehåll
refereegranskat (49)
övrigt vetenskapligt/konstnärligt (4)
Författare/redaktör
Kowalski, Marek (4)
Stenlund, Evert (3)
Blanco, F. (3)
Christiansen, Peter (3)
Dobrin, Alexandru (3)
Majumdar, A. K. Dutt ... (3)
visa fler...
Gros, Philippe (3)
Kurepin, A. (3)
Kurepin, A. B. (3)
Malinina, Ludmila (3)
Milosevic, Jovan (3)
Ortiz Velasquez, Ant ... (3)
Sogaard, Carsten (3)
Khaw, Kay-Tee (3)
Riboli, Elio (3)
Peskov, Vladimir (3)
Abelev, Betty (3)
Adamova, Dagmar (3)
Adare, Andrew Marsha ... (3)
Aggarwal, Madan (3)
Rinella, Gianluca Ag ... (3)
Agostinelli, Andrea (3)
Ahammed, Zubayer (3)
Ahmad, Nazeer (3)
Ahmad, Arshad (3)
Ahn, Sang Un (3)
Akindinov, Alexander (3)
Aleksandrov, Dmitry (3)
Alessandro, Bruno (3)
Alici, Andrea (3)
Alkin, Anton (3)
Almaraz Avina, Erick ... (3)
Alt, Torsten (3)
Altini, Valerio (3)
Altinpinar, Sedat (3)
Altsybeev, Igor (3)
Andrei, Cristian (3)
Andronic, Anton (3)
Anguelov, Venelin (3)
Anson, Christopher D ... (3)
Anticic, Tome (3)
Antinori, Federico (3)
Antonioli, Pietro (3)
Aphecetche, Laurent ... (3)
Appelshauser, Harald (3)
Arbor, Nicolas (3)
Arcelli, Silvia (3)
Arend, Andreas (3)
Armesto, Nestor (3)
Arnaldi, Roberta (3)
visa färre...
Lärosäte
Lunds universitet (20)
Uppsala universitet (15)
Umeå universitet (9)
Linköpings universitet (7)
Karolinska Institutet (7)
Kungliga Tekniska Högskolan (5)
visa fler...
Göteborgs universitet (4)
Stockholms universitet (4)
Luleå tekniska universitet (2)
Chalmers tekniska högskola (2)
Sveriges Lantbruksuniversitet (2)
Handelshögskolan i Stockholm (1)
Karlstads universitet (1)
visa färre...
Språk
Engelska (53)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (23)
Naturvetenskap (22)
Teknik (10)
Lantbruksvetenskap (1)
Samhällsvetenskap (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy